A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT06734871 · RECRUITING

Trial details

NCT number: NCT06734871
Sponsor: Aibin Liang，MD，Ph.D.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin Lymphoma

Start date: 2024-12-30
Primary completion: 2025-10-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.